Larvol Delta - TBBO8520101-A-Phase-1a1b-OpenLabel-Study-Evaluating-the-Safety-Tolerability-Pharmacokinetics-and-Efficacy-of-BBO8520-in-Subjects-with-Advanced-KRASG12C-Mutant-NonSmall-Cell-Lung-Cancer--The-ONKORAS101-Study

BBO-8520 - BridgeBio Oncology Therapeutics

Jun 22, 2026